Could eye drops replace needles for diabetic eye swelling?
NCT ID NCT06599684
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This small Phase 2 study tested INV-102 eye drops in 19 people with diabetic macular edema, a swelling in the back of the eye caused by diabetes. Participants used the drops daily for 8 to 12 weeks. The goal was to see if the drops could improve retinal health and reduce swelling. This is an early step toward a potential non-invasive treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- INV-102 ophthalmic solution (eye drops)
- What this could lead to
- If successful, this could lead to a simple eye drop treatment for diabetic macular edema, reducing the need for injections.
- What could go wrong
- This is a small, early-phase pilot study with only 19 participants. It may not show clear benefit, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CENTER INVOLVED DIABETIC MACULAR EDEMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
MedTrials, Inc.
Dallas, Texas, 75204, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI eye doctor: could software catch diabetic blindness sooner?
- Can a One-Time gene therapy offer lasting protection for diabetic retinopathy?
- Can eye scans reveal hidden clues about diabetes damage?
- AI could predict which eye treatments work best for Diabetes-Related vision loss
- New eye drug aims to restore vision in Diabetes-Related swelling
- New eye drug aims to restore vision in Diabetes-Related swelling